Yahoo
GARDEN CITY, NY, March 07, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and consumer products company, today announced that Ted Karkus, CEO, will be presenting at this year’s Investor Summit Virtual on March 11th. Event: Q1 Investor SummitPresentation Time: 1:30 P.M. ET Location: https://www.webcaster4.com/Webcast/Page/3082/52134 Conference Overview and StructureThe Investor Summit is an exclusive event for invest
Yahoo
Profound Medical (PROF) delivered earnings and revenue surprises of 33.33% and 0.55%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Yahoo
ProPhase Labs (PRPH) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Yahoo
New York, NY, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an Update Note on ProPhase Labs Inc. (NASDAQ: PRPH). The update note includes information on ProPhase’s business model, services offered, industry outlook, financial results, management commentary, and risks. The update note is available below. ProPhase Labs February 2025 Update Note Highlights from the note include: ProPhase L
Yahoo
Company Announces Ongoing Strategic Cost Cutting to Focus Resources on new DTC Marketing Initiatives to Drive Growth and Profitability Dispels rumors of an Investment Bank initiating a Capital Raise GARDEN CITY, NY, Feb. 25, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) ("ProPhase" or the "Company"), a next-generation biotech, genomics, and consumer products company provides a Company update and schedules a conference call for later today. Following the hiring of Stu Hollenshead, s
Yahoo
Company Actively Pursuing Strategic Alternatives Including the Potential Sale of Nebula Genomics and DNA Complete to Unlock Immediate Cash GARDEN CITY, NY, Feb. 20, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) ("ProPhase" or the "Company"), a next-generation biotech, genomics, and consumer products company, is focused on immediate cash generation through two key initiatives: strategic alternatives including a potential sale of its genomics assets and the aggressive collection of o
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
EDIT | 28.45% | $121.15M | -82.04% | 0.00% |
ADEA | 27.59% | $1.43B | +22.60% | 1.46% |
FLGT | 25.80% | $531.50M | -21.96% | 0.00% |
BRY | 25.71% | $259.67M | -54.02% | 12.88% |
EVH | 25.40% | $1.10B | -71.18% | 0.00% |
PSEC | 24.89% | - | - | 15.33% |
WTI | 24.59% | $230.31M | -39.77% | 2.58% |
EC | 24.44% | $20.83B | -8.16% | 15.36% |
MSGE | 23.10% | $1.50B | -15.99% | 0.00% |
WMS | 22.99% | $8.45B | -33.32% | 0.59% |
EDSA | 22.94% | $16.71M | -45.56% | 0.00% |
SSSS | 22.62% | - | - | 0.00% |
PINS | 22.46% | $21.67B | -6.55% | 0.00% |
ENTA | 22.08% | $141.86M | -53.20% | 0.00% |
LILA | 21.95% | $1.32B | +6.19% | 0.00% |
DVN | 21.91% | $22.42B | -27.24% | 3.86% |
KELYA | 21.70% | $463.66M | -45.56% | 2.29% |
FINV | 21.41% | $1.27B | +72.48% | 2.68% |
LILAK | 21.23% | $1.31B | +5.55% | 0.00% |
AEIS | 21.20% | $4.01B | +10.90% | 0.38% |
Current Value
$0.391 Year Return
Current Value
$0.391 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
MUNI | -16.99% | $1.80B | 0.35% |
DFIP | -16.63% | $861.16M | 0.11% |
LTPZ | -16.55% | $718.31M | 0.2% |
FLIA | -16.38% | $618.23M | 0.25% |
SCHP | -16.33% | $12.40B | 0.03% |
CGMU | -16.30% | $2.96B | 0.27% |
TIP | -16.21% | $14.28B | 0.18% |
GTIP | -16.00% | $143.55M | 0.12% |
DFNM | -15.47% | $1.50B | 0.17% |
SHYM | -14.62% | $307.19M | 0.35% |
SHM | -14.60% | $3.40B | 0.2% |
GOVZ | -14.49% | $289.93M | 0.1% |
LGOV | -14.40% | $661.19M | 0.67% |
GSST | -14.40% | $809.40M | 0.16% |
TFI | -14.01% | $3.64B | 0.23% |
GOVT | -13.97% | $28.51B | 0.05% |
TDTT | -13.72% | $2.32B | 0.18% |
TAXF | -13.71% | $519.57M | 0.29% |
SHYD | -13.70% | $319.95M | 0.35% |
EUSB | -13.67% | $681.72M | 0.12% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VNM | 18.91% | $414.35M | 0.7% |
CTA | 18.42% | $833.97M | 0.76% |
PXJ | 18.04% | $31.18M | 0.66% |
RSPG | 17.23% | $484.78M | 0.4% |
ICLO | 17.11% | $351.86M | 0.2% |
FXN | 16.70% | $323.88M | 0.62% |
EFAA | 16.49% | $93.45M | 0% |
XES | 15.92% | $172.35M | 0.35% |
FCG | 15.72% | $372.10M | 0.6% |
IGE | 15.62% | $600.68M | 0.41% |
FTXN | 15.62% | $146.46M | 0.6% |
IEO | 15.61% | $538.47M | 0.4% |
IYE | 15.60% | $1.25B | 0.39% |
CNBS | 15.48% | $67.47M | 0.77% |
WOOD | 15.43% | $238.80M | 0.41% |
XLE | 15.09% | $31.51B | 0.09% |
XOP | 15.02% | $2.02B | 0.35% |
GSG | 14.96% | $1.02B | 0.75% |
PXE | 14.93% | $81.56M | 0.63% |
MSOS | 14.81% | $359.31M | 0.83% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
DFGR | -<0.01% | $2.26B | 0.22% |
DBA | 0.01% | $837.99M | 0.93% |
EMLC | -0.02% | $2.80B | 0.3% |
VHT | 0.02% | $16.34B | 0.09% |
KSA | -0.05% | $617.42M | 0.75% |
REET | 0.07% | $3.69B | 0.14% |
RIET | 0.07% | $86.31M | 0.5% |
FVD | 0.08% | $9.04B | 0.6% |
FMF | 0.08% | $154.01M | 0.95% |
RSPH | 0.08% | $792.25M | 0.4% |
ARKX | -0.10% | $258.10M | 0.75% |
XSLV | 0.10% | $274.37M | 0.25% |
HYS | -0.10% | $1.42B | 0.56% |
CANE | 0.10% | $12.06M | 0.29% |
OMFL | -0.12% | $4.52B | 0.29% |
HEGD | 0.12% | $359.89M | 0.88% |
FBY | 0.14% | $157.48M | 1.06% |
KCCA | -0.16% | $106.20M | 0.87% |
FXY | 0.16% | $525.51M | 0.4% |
QGRO | 0.16% | $1.11B | 0.29% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SPB | 0.01% | $1.89B | -13.85% | 2.48% |
MMSI | 0.01% | $5.82B | +37.68% | 0.00% |
EXPI | 0.01% | $1.47B | -3.00% | 2.06% |
APD | 0.02% | $64.95B | +19.33% | 2.43% |
IART | 0.02% | $1.73B | -35.59% | 0.00% |
NCLH | 0.02% | $8.44B | -1.08% | 0.00% |
RLJ | -0.02% | $1.33B | -25.68% | 5.71% |
WEX | -0.02% | $5.98B | -33.64% | 0.00% |
WIT | 0.02% | $32.11B | +0.16% | 2.26% |
ZCMD | 0.03% | $30.28M | -32.91% | 0.00% |
NSIT | 0.03% | $4.81B | -18.56% | 0.00% |
VRNT | 0.03% | $1.35B | -28.85% | 0.00% |
TOWN | 0.04% | $2.60B | +29.96% | 2.91% |
EXEL | 0.05% | $10.26B | +59.49% | 0.00% |
LADR | -0.05% | $1.48B | +5.90% | 7.99% |
BAP | 0.05% | $15.06B | +11.54% | 4.92% |
WABC | 0.05% | $1.37B | +9.77% | 3.43% |
SWKS | -0.05% | $11.16B | -33.31% | 3.99% |
DXC | -0.05% | $3.13B | -16.28% | 0.00% |
NTST | -0.06% | $1.24B | -10.94% | 6.83% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TCTM | -29.07% | $3.03M | -79.68% | 0.00% |
AXON | -28.34% | $42.62B | +80.81% | 0.00% |
TASK | -26.06% | $1.23B | +10.78% | 0.00% |
NHTC | -22.23% | $58.65M | -22.70% | 15.87% |
BLKB | -20.85% | $3.12B | -10.56% | 0.00% |
ALRM | -18.85% | $2.90B | -20.07% | 0.00% |
SEZL | -18.49% | $1.31B | +299.78% | 0.00% |
DFIN | -18.23% | $1.24B | -30.48% | 0.00% |
VIAV | -18.02% | $2.43B | +10.95% | 0.00% |
FTRE | -18.01% | $871.33M | -75.42% | 0.00% |
UI | -17.31% | $19.30B | +187.74% | 0.76% |
DOCS | -17.24% | $11.89B | +127.33% | 0.00% |
NOC | -17.06% | $70.20B | +5.02% | 1.70% |
TEAM | -16.72% | $57.23B | +12.35% | 0.00% |
TNET | -16.05% | $3.71B | -40.35% | 1.33% |
COST | -15.76% | $401.25B | +24.57% | 0.51% |
ATRC | -15.76% | $1.63B | +3.64% | 0.00% |
WWW | -15.65% | $1.07B | +31.63% | 3.02% |
FARO | -15.60% | $558.63M | +46.35% | 0.00% |
WCN | -15.52% | $47.82B | +8.40% | 0.65% |